Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.
暂无分享,去创建一个
[1] D. Jakubowicz,et al. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. , 1996, The New England journal of medicine.
[2] E. Ferrannini,et al. Acute Antihyperglycemic Mechanisms of Metformin in NIDDM: Evidence for Suppression of Lipid Oxidation and Hepatic Glucose Production , 1994, Diabetes.
[3] R. Considine,et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.
[4] J. Lord,et al. Effect of metformin on insulin receptor binding and glycaemic control in type II diabetes. , 1983, British medical journal.
[5] H. Rüdiger,et al. Biguanide treatment increases the number of insulin-receptor sites on human erythrocytes. , 1981, The New England journal of medicine.
[6] J. Bue-Valleskey,et al. The role of neuropeptide Y in the antiobesity action of the obese gene product , 1995, Nature.
[7] J. Morley. Neuropeptide regulation of appetite and weight. , 1987, Endocrine reviews.
[8] S. P. Grossman. The role of glucose, insulin and glucagon in the regulation of food intake and body weight , 1986, Neuroscience & Biobehavioral Reviews.
[9] E. Rolls,et al. Pleasantness changes and food intake in a varied four-course meal , 1984, Appetite.
[10] C. Bailey. Biguanides and NIDDM , 1992, Diabetes Care.
[11] R. Jung,et al. Energy expenditure in non-insulin dependent diabetic subjects on metformin or sulphonylurea therapy. , 1987, Clinical science.
[12] A. Mushlin,et al. A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination. , 1984, Archives of internal medicine.
[13] G Dailey,et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.
[14] Stone Db. Treatment of the obese diabetic patient. , 1967 .
[15] B. Clarke,et al. Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet. , 1977, British medical journal.
[16] R. Campbell,et al. Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. , 1977, Science.
[17] W. Klein. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients. , 1991, Diabete & metabolisme.
[18] I. Stein,et al. Vagotomy and the hunger-producing action of insulin in man. , 1948, Journal of applied physiology.
[19] S. Woods,et al. Insulin in the brain: a hormonal regulator of energy balance. , 1992, Endocrine reviews.
[20] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[21] Hermann Ls. Metformin: a review of its pharmacological properties and therapeutic use. , 1979 .
[22] R. Vigneri,et al. Treatment of NIDDM patients with secondary failure to glyburide: comparison of the addition of either metformin or bed-time NPH insulin to glyburide. , 1991, Diabete & metabolisme.
[23] T. Koschinsky,et al. Oral antidiabetic combination therapy with sulphonylureas and metformin. , 1991, Diabete & metabolisme.
[24] L. S. Hermann,et al. Comparative efficacy of metformin and glibenclamide in patients with non-insulin-dependent diabetes mellitus. , 1991, Diabete & metabolisme.
[25] G. Bray,et al. A randomized double-blind clinical trial of fluoxetine in obese diabetics. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[26] L. J. Duncan,et al. Weight-reducing Effect of Diguanides in Obese Non-diabetic Women , 1969, British medical journal.
[27] G. Bray,et al. Insulin secretion in hypothalamic obesity: diurnal variation and the effect of naloxone. , 1993, Obesity research.
[28] S. Woods,et al. Intraventricular insulin reduces food intake and body weight of lean but not obese zucker rats , 1986, Appetite.
[29] L. Campfield,et al. Insulin normalization as an approach to the pharmacological treatment of obesity. , 1995, Obesity research.
[30] D. Porte,et al. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats , 1990, Peptides.
[31] B. Clarke,et al. Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics. , 1968, Lancet.
[32] B. Guy-grand,et al. INTERNATIONAL TRIAL OF LONG-TERM DEXFENFLURAMINE IN OBESITY , 1989, The Lancet.
[33] A. Stunkard,et al. The anorectic effect of dexamphetamine sulphate. , 1968, British journal of pharmacology and chemotherapy.
[34] I. Leck,et al. PREVALENCE AND DURATION OF UNDETECTED BREAST CANCER , 1975, The Lancet.
[35] H. Kissileff,et al. A Quadratic Equation Adequately Describes the Cumulative Food Intake Curve in Man , 1982, Appetite.